How much is Serinus Biosciences worth in 2026?

Serinus Biosciences has a current valuation of N/A based on their Seed Round round and secondary market data.

How much funding has Serinus Biosciences raised?

Serinus Biosciences has raised N/A in total funding across 1 funding rounds.

Serinus Biosciences

Drug Discovery

Serinus Biosciences valuation and funding history | Last updated: September 30, 2022 | 1 funding rounds

Current Valuation

N/A

As of September 30, 2022

Total Funding Raised

N/A

Across 1 round

Last Round

Seed Round

$4.0M

Last Funding

Sep 2022

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
September 30, 2022	Seed Round	$4.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Serinus Biosciences is currently valued at N/A as of September 30, 2022.

Track Serinus Biosciences Valuation Updates

Get notified when Serinus Biosciences raises new funding or valuation changes

Explore More Data

Detailed analysis for Serinus Biosciences

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Serinus Biosciences's valuation history, funding rounds, and growth metrics.

No credit card required

What is Serinus Biosciences Worth in 2026?

Serinus Biosciences is a leading private company in the Drug Discovery sector. Track Serinus Biosciences's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Serinus Biosciences Valuation is Determined

Private company valuations like Serinus Biosciences's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.